Drawing for CRAFT

USPTO serial 98220927

CRAFT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SCHRADER, BRITTANY A
Law office
TMO LAW OFFICE 127

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CRAFT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas Y. Yee

Thomas Y. Yee PERKINS COIE LLPP.O. BOX 2608SEATTLE, WA 98111United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and data management in the field of clinical trials, namely, providing information management services by means of data compilation; collection, reporting, visualizing, and analysis of healthcare records, clinical records, and life science report and article-related data for business purposes; services consisting of the registration, collection, transcription, compilation, clarification, enablement, enhancement, management, mapping, visualization, and systemization of written communications and data; all of the foregoing services may also be provided by means of artificial intelligenceACTIVE—
038Providing access to an electronic exchange of health data and data analyses across an integrated nationwide clinical research network; transmission of health and medical record and life science report and article database information and analyses of health and medical record and life science report and articles database information via telecommunications networks; electronic exchange of health data and life science report and articles insights via telecommunication networks for analyses and visualization of health data from clinicians, health systems, academic medical centers, life sciences companies, and others; electronic transmission of health data; all of the foregoing services may also be provided by means of artificial intelligenceACTIVE—
042Providing medical, health, and scientific research information, research data, and research services to assist healthcare providers, healthcare professionals, and life sciences companies in making informed decisions for patient diagnosis and treatment and clinical trial design, emulation, strategy, and prioritization; medical research services, namely, collecting, storing, indexing, analyzing, updating, managing, sharing, and reporting real world data to create actionable insights for use by healthcare providers, healthcare professionals, and life sciences companies; providing medical and scientific research information in the field of clinical trials and life sciences; compiling data for research purposes in the field of medical science and medical consultancy and life sciences; software as a service (SAAS) services featuring software for providing diagnosis and treatments recommendations for physicians and researchers; software as a service (SAAS) services featuring software for collecting, storing, indexing, analyzing, updating, managing, sharing, clarifying, enabling, enhancing, managing, mapping, visualizing and reporting clinical trial, data, electronic health records, claims data, life science articles and report, and medical research data to evaluate and recommend medical diagnoses and treatments; software as a service (SAAS) services featuring software for searching, organizing and managing data, namely, demographics, diagnoses, procedures, medications, laboratory values, clinical notes, mortality, and length of stay information for patients to inform clinical care decisions and research; software as a service (SAAS) services featuring software for providing healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; software as a service (SAAS) services featuring software for compiling, clarifying, enabling, enhancing, managing, mapping, visualizing, and analyzing medical records and health data and life science articles and reports; software as a service (SAAS) services featuring software using a natural language or large language model, artificial intelligence, and machine learning for compiling, clarifying, enabling, enhancing, managing, mapping, visualizing and analyzing medical records and health data and life science articles and reports; software as a service (SAAS) services featuring chatbot software using a natural language or large language model or artificial intelligence for compiling, clarifying, enabling, enhancing, managing, mapping, and analyzing medical records and health data and life science articles and reports and providing tailored reports regarding the data to physicians and researchers; compiling data for research purposes in the field of medical science and medical consultancy; software as a service (SAAS) services featuring software for data visualization; software as a service (SAAS) services featuring software for patient data analysis and visualization relating to clinical trial performance; providing medical and scientific research information in the field of clinical trialsACTIVE—
044Providing medical information to healthcare providers and healthcare professionals, and life sciences companies to help them make informed decisions for patient diagnosis and treatment and clinical trial design, emulation, strategy, and prioritization; providing health data analysis and visualization to healthcare providers and healthcare professionals in the medical and patient-care industry to help them to assess clinical data for the purpose of patient diagnosis and treatment and improving quality of care in the medical and healthcare industry; providing information and data related to patient data, namely, demographics, diagnoses, procedures, medications, laboratory values, clinical notes, mortality, and length of stay information for patients to inform clinical care decisions and research and to inform life science company corporate strategy, research and development, and marketing and brand planning; providing on-line medical and clinical record and life science articles and reports analysis services designed to provide healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; providing on-line medical and clinical record and life science articles and reports analysis and visualization services designed to provide medical providers with custom tailored information about the outcomes for patients with similar symptoms and evidence needed for patient care decisions; compiling, clarifying, enabling, enhancing, managing, mapping, visualizing, and analyzing medical and clinical data and life science articles and reports for medical treatment purposes; all of the foregoing services may also be provided by means of artificial intelligenceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 3, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 3, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 15, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 15, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 16, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 17, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 26, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 26, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Aug 26, 2024CNSLSUSPENSION LETTER WRITTEN—
Jun 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 25, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2024DOCKASSIGNED TO EXAMINER—
Oct 16, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 16, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance